Skip to main content
. 2024 Jul 24;16(15):2636. doi: 10.3390/cancers16152636

Figure 4.

Figure 4

Pegvisomant attenuates exosome-induced cell migration in melanoma. Changes in wound closure following administration with 20 μg/mL exosomes, isolated from melanoma cells treated with 50 ng/mL GH independently or in combination with EC50 dosage of doxorubicin and 500 nM pegvisomant. Representative images for cell migration at the indicated time points are shown for SK-MEL-28 (A), SK-MEL-30 (C), and their respective quantifications (B,D). Three independent experiments were performed and presented as the mean ± SD and p < 0.05 (*), and p < 0.001 (***).